VetMedGuide

Vet Med Guide

Pharmaceuticals2026-05-14 · 11 min read

One-Dose Dog Ear Medication vs Daily Drops: Rechecks, Failure Patterns

Claro (single dose), Osurnia (two doses), and daily ear drops like Mometamax and Posatex are all FDA-approved for canine otitis externa.

Ran Chen
Ran Chen
Founder, VetMedGuide. Life-sciences operator and 10× global market-access lead.
Published

The FDA has approved three categories of topical treatment for canine otitis externa: a single-dose veterinarian-administered product (Claro), a two-dose veterinarian-administered product (Osurnia), and multiple daily-use topical products that owners apply at home (Mometamax, Posatex, Otomax, Easotic, Surolan, and others).

The question for veterinarians and pet owners is not which product is "best." It is which approach fits the dog, the infection, and the owner. The answer depends on what the cytology shows, how reliably the owner can medicate the ear, whether the infection is acute or chronic, and what happens at the recheck.

The veterinarian-administered options

Claro (florfenicol, terbinafine, mometasone furoate)

Claro was the first FDA-approved single-dose treatment for canine otitis externa, approved in September 2015. It is now marketed by Elanco.

What it contains:

  • Florfenicol 16.6 mg/mL — antibiotic (effective against susceptible Staphylococcus pseudintermedius)
  • Terbinafine 14.8 mg/mL — antifungal (effective against Malassezia pachydermatis)
  • Mometasone furoate 2.2 mg/mL — corticosteroid (reduces inflammation and swelling)

Dosing: One 1 mL dose per affected ear, administered once by veterinary personnel. The label states the duration of effect lasts up to 30 days. The ear should not be cleaned after dosing, as this may reduce effectiveness.

Key label points:

  • Contraindicated in dogs with known tympanic membrane perforation; the tympanic membrane should be confirmed intact before administration
  • Not approved for use in cats — extra-label use in cats has been associated with ataxia, anorexia, vestibular signs, Horner's syndrome, and deafness
  • Post-approval adverse events include ear discharge, head shaking, ataxia, vestibular signs, deafness, vomiting, nystagmus, and tympanic membrane rupture
  • Human safety warning: may cause eye injury; veterinary personnel should wear eye protection
  • The safe use in breeding, pregnant, or lactating dogs has not been evaluated

Label indication: Treatment of otitis externa in dogs associated with susceptible strains of yeast (Malassezia pachydermatis) and bacteria (Staphylococcus pseudintermedius).

A generic equivalent (Klentz, by Aurora Pharmaceutical) was approved by the FDA in December 2025 under ANADA 200-829.

Osurnia (florfenicol, terbinafine, betamethasone acetate)

Osurnia was approved in November 2014 and is now marketed by Dechra.

What it contains:

  • Florfenicol 10 mg/mL — antibiotic
  • Terbinafine 10 mg/mL — antifungal
  • Betamethasone acetate 1 mg/mL — corticosteroid

Dosing: One 1 mL dose per affected ear, administered on day 0 and again on day 7 — two applications total, both by veterinary personnel. The ear should not be cleaned for 45 days after the initial administration.

Key label points:

  • Same tympanic membrane contraindication as Claro
  • Not approved for use in cats
  • Post-approval adverse events include vomiting, increased liver enzymes, hearing loss, ear discharge, irritation, head shaking, vestibular signs, tympanic rupture, and facial paralysis
  • The European label additionally contraindicates use in pregnant or breeding animals and in dogs with generalized demodicosis

Label indication: Treatment of otitis externa in dogs associated with susceptible strains of bacteria (Staphylococcus pseudintermedius) and yeast (Malassezia pachydermatis).

The daily at-home options

Several FDA-approved topical ear medications require the owner to apply drops at home, typically once or twice daily for 7 to 14 days.

Product Antibiotic Antifungal Corticosteroid Dosing
Mometamax Gentamicin Clotrimazole Mometasone Once daily × 7 days
Posatex Orbifloxacin Posaconazole Mometasone Once daily × 7–14 days
Otomax Gentamicin Clotrimazole Betamethasone Twice daily × 7–14 days
Easotic Gentamicin Miconazole Hydrocortisone aceponate Once daily × 5 days
Surolan Polymyxin B Miconazole Prednisolone Twice daily × 7–14 days
Baytril Otic Enrofloxacin Silver sulfadiazene None Twice daily × 7–14 days

Each product has a specific antimicrobial profile. The choice should be driven by cytology findings — cocci, yeast, rods, or a combination — rather than habit or formulary preference.

What the evidence says about efficacy

A 2026 systematic review published in Veterinary Evidence critically appraised three randomized controlled studies comparing single-dose or two-dose veterinarian-administered protocols with daily at-home treatments. The review reached the following conclusions:

  • Both approaches were effective. There was no significant difference in final outcomes between veterinarian-administered (Claro/Osurnia) and daily at-home protocols.
  • A 2024 study found Mometamax Ultra (single-dose) successful in 128 of 143 dogs, and Osurnia (two-dose) successful in 116 of 133 dogs, with no difference in relapse rates.
  • A 2018 study noted a slightly faster initial response at day 7 with daily treatment, but by day 28 and day 56, there were no significant differences in cytology counts, pain scores, or pruritus between the groups.
  • Relapse rates were low and comparable across both approaches.

The strength of evidence was rated as strong by the review authors.

Compliance: the real deciding factor

The primary clinical advantage of veterinarian-administered products is not superior efficacy — the evidence shows they are equally effective. It is compliance.

Owner compliance with daily ear medication is widely acknowledged to be poor. Dogs resist ear drops. Owners forget doses. The medication course is stopped early because the ear looks better. A medication that is only 50% effective but is actually given is more useful than a medication that is 100% effective in a study but is given inconsistently.

Veterinarian-administered products eliminate this variable. The dose goes in correctly, at the right depth, after proper cleaning, every time.

This is why many veterinary dermatologists reserve daily at-home medications for specific situations:

  • Owners who are reliable and experienced with ear handling
  • Infections where the organism requires a specific antimicrobial not covered by Claro or Osurnia
  • Cases where more frequent re-evaluation and dose adjustment is needed
  • Dogs where the cost of in-clinic visits for each dose is prohibitive

Where each approach fits

Best fit for Claro or Osurnia

  • Acute, uncomplicated otitis externa with cocci and/or yeast on cytology
  • Owners who cannot reliably medicate ears at home — due to the dog's temperament, the owner's schedule, or physical limitations
  • Dogs with a history of non-compliance-related treatment failure
  • Situations where the veterinary visit itself ensures the ear is properly cleaned before treatment

When daily at-home drops may be preferable

  • Rod-shaped bacteria on cytology — Pseudomonas and other gram-negative rods may not respond to florfenicol. Culture-directed therapy with a fluoroquinolone or other agent is often more appropriate. Baytril Otic (enrofloxacin + silver sulfadiazene) or compounded formulations may be needed.
  • Known tympanic membrane rupture — both Claro and Osurnia are contraindicated. Some daily medications can be used with caution in this situation, though the choice depends on ototoxicity risk.
  • Chronic otitis requiring serial re-evaluation — when the treatment plan needs to change based on cytology at intervals shorter than 30 days.
  • Yeast-only infections where a targeted antifungal without an antibiotic may be preferred to reduce unnecessary antibiotic exposure.
  • Cases where cost is a primary concern — generic daily medications are often less expensive than a single in-clinic application of Claro or Osurnia.

The recheck strategy differs

The recheck protocol for veterinarian-administered products and daily medications is not the same, and this difference matters.

For Claro (single dose)

The label states the duration of effect is up to 30 days. The recheck should occur at approximately 30 days. At that visit, cytology should be repeated — even if the ear looks normal — to confirm the infection has resolved.

If organisms persist at 30 days, the next step depends on what cytology shows:

  • Same organisms still present: consider whether the underlying cause was addressed, and whether a different treatment is needed
  • New or different organisms: the initial treatment may have altered the canal flora
  • Persistent inflammation without organisms: suspect an underlying primary cause (allergy, endocrinopathy)

One limitation: if the infection is not resolving, you cannot easily adjust the medication mid-course. The dose has already been given. The next step is either another round of Claro, a different product, or further diagnostics.

For Osurnia (two doses, days 0 and 7)

The second dose is administered at the day-7 visit, regardless of how the ear looks. The ear should not be cleaned between doses or for 45 days after the first dose. The recheck for cytology evaluation occurs after the full treatment period.

The same limitations apply: if the product is not working, the course has already been committed.

For daily at-home medications

The veterinarian has more flexibility to adjust mid-treatment. If a recheck at 7 to 14 days shows persistent organisms, the medication can be changed, extended, or augmented. For severe or chronic cases, this adaptability is an advantage.

An advanced strategy: monthly maintenance for chronic otitis

For dogs with chronic, recurrent otitis externa where the underlying cause cannot be fully eliminated — most commonly allergic dogs — some veterinary dermatologists use Claro or Osurnia on a monthly basis as maintenance therapy. This is an off-label protocol: the products are labeled for treatment of active infections, not for prophylactic use. But in specialist practice, monthly application can keep the ear canal microenvironment controlled enough to prevent overt clinical recurrence between allergy management steps.

This approach is typically reserved for cases where:

  • Cytology between flare-ups still shows abnormal organism counts
  • The dog has failed standard maintenance with ear cleaners and anti-inflammatory drops
  • The owner and veterinarian have discussed the tradeoff between repeated corticosteroid exposure in the ear canal and the alternative of repeated active infections

If your dog is on a monthly ear treatment protocol, the conversation should include what cumulative corticosteroid exposure means for that individual dog, and whether there are additional steps (dietary trials, immunotherapy, systemic allergy medications) that might reduce the need for ongoing topical treatment.

Failure patterns to watch for

Regardless of which approach is used, certain patterns indicate the treatment plan needs to change:

  • Clinical improvement followed by rapid recurrence — this almost always means the underlying primary cause has not been identified or managed. Allergy is the most common culprit.
  • No improvement at all — the organism may not be susceptible to the chosen medication, or there may be a perpetuating factor (stenosis, otitis media, foreign body, mass) that medication alone cannot overcome.
  • New organism on recheck cytology — the initial treatment cleared one infection but altered the canal environment enough to allow a different organism to flourish.
  • Persistent inflammation with negative cytology — this points to a non-infectious primary cause. Continuing antimicrobials will not help.

What this means for pet owners

If your dog has an ear infection, the conversation with your veterinarian should include:

  1. "What did the cytology show?" — Before any medication is chosen, a swab should be taken and examined under the microscope. If this step is skipped, ask for it.

  2. "Is my dog a candidate for a one-dose treatment?" — If the cytology shows cocci and/or yeast, the tympanic membrane is intact, and the dog is not a cat, Claro or Osurnia may be appropriate. If rods are present, a different approach is usually needed.

  3. "When should we recheck?" — For Claro, plan on approximately 30 days. For Osurnia, the second dose is at day 7 and the full recheck follows. For daily medications, a recheck at the end of the course is standard. In all cases, cytology at recheck is essential.

  4. "If the infection comes back, what is the next step?" — Recurrent ear infections are a signal that an underlying cause needs to be investigated. Ask about allergy workups, dietary trials, or referral to a dermatologist.

  5. "Can I reliably medicate my dog's ears at home?" — Be honest with yourself and your veterinarian. If the answer is no, a veterinarian-administered product may be the safer choice.

Sources

Topics
DermatologyAntibiotics & Anti-Infectives
Related Articles